Howe & Rusling’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.21M Sell
29,487
-503
-2% -$117K 0.47% 62
2025
Q4
$6.21M Buy
29,990
+8,520
+40% +$1.68M 0.41% 68
2025
Q3
$3.98M Buy
21,470
+2,020
+10% +$346K 0.27% 83
2025
Q2
$2.97M Sell
19,450
-3,696
-16% -$568K 0.22% 87
2025
Q1
$3.84M Sell
23,146
-795
-3% -$124K 0.32% 79
2024
Q4
$3.46M Sell
23,941
-54,388
-69% -$8.43M 0.3% 80
2024
Q3
$12.7M Buy
78,329
+178
+0.2% +$28.4K 1.09% 25
2024
Q2
$11.4M Sell
78,151
-714
-0.9% -$106K 1.04% 30
2024
Q1
$12.5M Sell
78,865
-25,815
-25% -$4.11M 1.2% 20
2023
Q4
$16.4M Sell
104,680
-24,837
-19% -$3.81M 1.74% 12
2023
Q3
$20.2M Sell
129,517
-16,369
-11% -$2.7M 2.38% 8
2023
Q2
$24.1M Sell
145,886
-19,996
-12% -$3.23M 2.7% 7
2023
Q1
$25.7M Sell
165,882
-1,299
-0.8% -$210K 3.06% 4
2022
Q4
$29.5M Buy
167,181
+6,947
+4% +$1.2M 3.7% 1
2022
Q3
$26.2M Buy
160,234
+674
+0.4% +$114K 3.48% 1
2022
Q2
$28.3M Buy
159,560
+12,663
+9% +$2.26M 3.59% 2
2022
Q1
$26M Sell
146,897
-282
-0.2% -$48K 3.01% 4
2021
Q4
$25.2M Buy
147,179
+16,176
+12% +$2.65M 2.95% 4
2021
Q3
$21.2M Buy
131,003
+911
+0.7% +$155K 2.65% 6
2021
Q2
$21.4M Sell
130,092
-1,815
-1% -$300K 2.7% 6
2021
Q1
$21.7M Sell
131,907
-4,937
-4% -$799K 2.94% 4
2020
Q4
$21.5M Sell
136,844
-575
-0.4% -$84.9K 3.27% 4
2020
Q3
$20.5M Sell
137,419
-2,817
-2% -$417K 3.51% 4
2020
Q2
$19.7M Sell
140,236
-3,430
-2% -$500K 3.64% 4
2020
Q1
$18.8M Buy
143,666
+37,878
+36% +$5.37M 4.06% 4
2019
Q4
$15.4M Sell
105,788
-319
-0.3% -$43.3K 2.55% 5
2019
Q3
$13.7M Sell
106,107
-30
-0% -$3.95K 2.41% 5
2019
Q2
$14.8M Sell
106,137
-7,766
-7% -$1.07M 2.55% 4
2019
Q1
$15.9M Buy
113,903
+881
+0.8% +$118K 2.76% 4
2018
Q4
$14.6M Sell
113,022
-2,816
-2% -$393K 3.09% 4
2018
Q3
$16M Buy
115,838
+779
+0.7% +$104K 2.67% 7
2018
Q2
$14M Buy
115,059
+2,279
+2% +$284K 2.53% 7
2018
Q1
$14.5M Buy
112,780
+30,326
+37% +$4.1M 2.62% 3
2017
Q4
$11.5M Sell
82,454
-3,002
-4% -$418K 2.09% 9
2017
Q3
$11.1M Buy
85,456
+255
+0.3% +$33.8K 2.06% 9
2017
Q2
$11.3M Buy
85,201
+2,146
+3% +$274K 2.29% 8
2017
Q1
$10.3M Buy
83,055
+1,958
+2% +$234K 2.07% 9
2016
Q4
$9.34M Buy
81,097
+1,262
+2% +$146K 2.05% 9
2016
Q3
$9.43M Buy
79,835
+3,277
+4% +$398K 2.03% 9
2016
Q2
$9.29M Buy
76,558
+1,909
+3% +$217K 2.04% 9
2016
Q1
$8.08M Buy
74,649
+4,488
+6% +$465K 1.82% 6
2015
Q4
$7.21M Buy
70,161
+4,375
+7% +$440K 1.65% 12
2015
Q3
$6.14M Buy
65,786
+2,390
+4% +$231K 1.52% 16
2015
Q2
$6.18M Buy
63,396
+5,809
+10% +$582K 1.35% 23
2015
Q1
$5.79M Sell
57,587
-6,454
-10% -$656K 1.3% 29
2014
Q4
$6.7M Buy
64,041
+461
+0.7% +$48.6K 1.61% 18
2014
Q3
$6.78M Buy
63,580
+571
+0.9% +$59.2K 1.58% 15
2014
Q2
$6.59M Buy
63,009
+1,679
+3% +$170K 1.48% 17
2014
Q1
$6.02M Buy
61,330
+2,520
+4% +$234K 1.48% 25
2013
Q4
$5.39M Buy
58,810
+9,198
+19% +$848K 1.36% 26
2013
Q3
$4.3M Sell
49,612
-13,722
-22% -$1.23M 1.57% 17
2013
Q2
$5.44M Buy
+63,334
New +$5.37M 1.51% 19

Other funds holding JNJ

Howe & Rusling's JNJ Position: Q1 2026 in Review

Howe & Rusling reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q1 2026, selling an estimated $117K and leaving 29,487 shares worth $7.21M. The position accounts for 0.47% of the portfolio, ranked #62.

Howe & Rusling first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $29.5M in Q4 2022. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Howe & Rusling held 29,487 shares of Johnson & Johnson worth $7.21M as of Q1 2026.
  • Howe & Rusling sold 503 Johnson & Johnson shares in Q1 2026, an estimated $117K.
  • Johnson & Johnson made up 0.47% of Howe & Rusling's portfolio in Q1 2026, its #62 holding.
  • Howe & Rusling first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Howe & Rusling's Johnson & Johnson position peaked at $29.5M in Q4 2022.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Howe & Rusling's 13F filing for Q1 2026, filed 28 Apr 2026.